United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 4 minute read General business news KKR wins £4.7bn takeover of Spectris, outbidding Advent with premium cash offer Discover how KKR clinched Spectris for £4.7 billion and why this takeover marks a pivotal moment in UK industrials—read more now! byPallavi MadhirajuJuly 2, 2025